Sign Out
SPIRIVA/SPIRIVA RESPIMAT is contraindicated in patients with a history of hypersensitivity to tiotropium bromide, atropine or its derivatives, e.g. ipratropium or oxitropium or to any other component of this product (see list of excipients in Description).
Spiriva: Tiotropium bromide inhalation powder is contraindicated in patients with a hypersensitivity to the excipient lactose monohydrate which contains milk protein.
